What they build
Open roles via the TechTO Job Board
Working at Allergan
Browse open roles across the community on the TechTO Job Board — Canada’s most connected tech network. Allergan’s roles show up here whenever they post.
Open roles on the TechTO Job Board ↗Or their own careers page: allergan.com/careers ↗Jobs live on jobs.techto.org — the only structured source. We link to it rather than scraping career sites, so the board is always the source of truth.
On the TechTO stage
Every talk is searchable — ask the archive about Allergan ↗
About
Martin Husar, then director of digital transformation at Allergan, took the MarketingTO stage in August 2019 with three digital trends he argued the pharmaceutical industry was ready to implement — including process mining as a way to see where work actually flows rather than where the org chart says it should. The talk is a useful record of what digital change looks like inside a regulated industry, where claims are approved rather than tested, audiences are physicians rather than consumers, and legacy systems predate the tools everyone else takes for granted. Allergan itself was acquired by AbbVie in a cash-and-stock deal worth US$63 billion, completed on 8 May 2020; its aesthetics portfolio now trades as Allergan Aesthetics, an AbbVie company.
Backers
Part of AbbVie since May 2020. Allergan plc was publicly traded before the acquisition.
Quick answers
Who owns Allergan?
AbbVie, which completed a US$63 billion cash-and-stock acquisition on 8 May 2020. The aesthetics business now operates as Allergan Aesthetics, an AbbVie company.
What did Allergan present at TechTO?
Martin Husar, its director of digital transformation, gave three digital trends he believed pharma was ready to implement, at MarketingTO in August 2019 — practical approaches rather than speculative bets, including process mining.
Why is digital transformation different in pharma?
Husar's argument was that regulated claims, long approval cycles, physician rather than consumer audiences, and legacy systems change what is possible, so tools that work elsewhere have to be adapted rather than adopted.